New at Content Charisma Blog

A collection of fresh stories on industry leadership, marketing insights about agility and resilience, and roadmaps for growth in today’s competitive marketplaces.

Digital marketing is a new ball game for pharmaceutical companies. Many countries, including the US and the UAE, have strict digital-domain specific regulations on marketing pharmaceuticals. A clear understanding of these laws is necessary for marketers to avoid penalties and damage to the company's reputation.
B2B organizations are feeling the heat of the changing behavior of buyers. According to Pavilion Pulse Benchmarking Survey dated August 2022, 68 percent of businesses reported missing their sales target in July 2022. Where are they going wrong? What are they not seeing? These insights will help B2B marketers win in today's unforgiving buying environment.
Over the past few years, medtech companies have been ramping up their digital-marketing capabilities and budgets. They developed skills and expertise to design and implement digital marketing. They used emails, social media, and other channels, and increased their reach through search engine optimization and search engine marketing. Yet, the results do not seem exciting. So, what are they missing?
Companies that strategically unify creativity, analytics, and purpose deliver at least twice the growth of their peers. By unifying the three elements, they could build a content model that enables personalized content creation. It is a magical way to engage with people's minds and hearts and onboard them, generating a meaningful and measurable difference in the company's bottom line.